Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Growth

Add To Compare

31.156 (-0.003%)
NAV on August 19, 2025
Category Equity:
Sector - Healthcare
Total Assets 1,339 cr
Turnover Ratio 11.18%
Expense Ratio 2.10%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 1.25%
  • 1Y: 4.55%
  • 3M: 4.93%
  • 3Y: 24.06%
  • 6M: 11.80%
  • 5Y: 19.04%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since 11 months)
ISIN INF277K016A9
Fund Family Tata
P/E Ratio 39.82
P/B Ratio 6.05
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
CREDIT QUALITY (%)
AAA -
AA -
A -
BBB -
BB -
B -
Below B -
Unrated -
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 2.30
Beta 0.94
R-Squared 96.44
Info Ratio 0.60
Tracking Err 3.12
Sortino 1.865
Sharpe 1.046
Std Dev 15.778
Risk -
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
497.145 12.02% 4,027 cr 0.91% -


Other plans of Tata India Pharma & Healthcare

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund